BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 10483868)

  • 1. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K; Macielag MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial resistance against beta-lactam antibiotics].
    Andersen BM
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M
    Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [beta-Lactam antibiotics--mechanisms of action and resistance in Enterobacteriaceae].
    Lausová A; Bujdáková H; Kettner M
    Epidemiol Mikrobiol Imunol; 1997 May; 46(2):73-80. PubMed ID: 9264797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Lode H
    Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-lactam antibiotics].
    Suárez C; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
    Semenitz E
    Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new in antibiotic resistance? Focus on beta-lactamases.
    Babic M; Hujer AM; Bonomo RA
    Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
    Buynak JD
    Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control].
    Dolapçi I
    Mikrobiyol Bul; 2005 Apr; 39(2):229-40. PubMed ID: 16128036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial resistance to antibiotics: biologic and ecologic aspects].
    Cavallo G
    G Batteriol Virol Immunol; 1988; 81(1-12):96-116. PubMed ID: 3079150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, beta-lactam antibiotics and antibiotic resistance mechanisms.
    Grail BM; Payne JW
    J Mol Recognit; 2002; 15(3):113-25. PubMed ID: 12203837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guides for rational use of B-lactam antibiotics:resistance mechanism and clinical interpretation].
    Arias CA; Panesso D; Zúñiga M
    Biomedica; 2003 Jun; 23(2):134-40. PubMed ID: 12872552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.